TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Xylophane AB
Closing information (x1000 SEK)
| Closing information | 2015/12 | 2014/12 | 2013/12 |
| Turnover |
1,688
|
64
|
184 |
| Financial expenses |
471
|
340
|
3,694 |
| Earnings before taxes |
-6,683
|
-6,779
|
-7,934 |
| EBITDA |
-4,915
|
-5,562
|
-3,359 |
| Total assets |
48,270
|
51,395
|
47,966 |
| Current assets |
4,025
|
6,935
|
6,363 |
| Current liabilities |
9,664
|
6,103
|
36,631 |
| Equity capital |
38,007
|
44,690
|
10,708 |
| - share capital |
408
|
408
|
431 |
| Employees (average) |
6
|
6
|
8 |
Financial ratios
| Fiscal year | 2015/12 | 2014/12 | 2013/12 |
| Solvency |
78.7%
|
87.0%
|
22.3% |
| Turnover per employee |
281
|
11
|
23 |
| Profit as a percentage of turnover |
-395.9%
|
-10592.2%
|
-4312.0% |
| Return on assets (ROA) |
-12.9%
|
-12.5%
|
-8.8% |
| Current ratio |
41.6%
|
113.6%
|
17.4% |
| Return on equity (ROE) |
-17.6%
|
-15.2%
|
-74.1% |
| Change turnover | |||
| Change turnover % |
2538%
|
-65%
|
-80% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
0%
|
-25%
|
-33% |
Total value of public sale
| Fiscal year | 2015/12 | 2014/12 | 2013/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.